Skip to main content

Marc Rodrigo Gisbert

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Marc Rodrigo Gisbert

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

Early identification of intracranial atherosclerosis-related large vessel occlusion (ICAS-LVO) and implications in endovascular treatment

IP: Marc Ribó Jacobi
Collaborators: Marc Rodrigo Gisbert
Funding agency: Fundació Institut de Recerca HUVH
Funding: 59681.19
Reference: DORADO/2024/RODRIGO
Duration: 08/06/2024 - 07/06/2026

Optimització del tractament endovascular a l'ictus isquèmic agut

IP: Mª Ángeles Muchada López
Collaborators: Marc Rodrigo Gisbert, Laia Perez Lasarte
Funding agency: Fundació Institut de Recerca HUVH
Funding: 35000
Reference: CARLESM/MARC_RG
Duration: 08/06/2023 - 07/06/2024

HARMONICS. Harmonization and Implementation of High Value Stroke Care

IP: Carlos Molina Cateriano
Collaborators: Maria Baladas Orti, Ester Sanchez Gavilan, Cristina Guirao Martinez, Estefania Montiel, Marina Jimenez Iglesias, Lidia Garcia Guillamón, Federica Rizzo, Marta Aurora Rubiera Del Fueyo, David Rodriguez Luna, Manuel Requena Ruiz, Marta Olive Gadea, Alvaro Garcia Tornel Garcia Camba, Marc Rodrigo Gisbert
Funding agency: EUROPEAN COMMISSION
Funding: 468090
Reference: HARMONICS_EIT-HEALTH-BP2022
Duration: 01/01/2022 - 31/12/2024

NORA-HOME. EFICIENCIA Y SEGURIDAD DE UN MODELO DE MONITORIZACION MULTIMODAL AMBULATORIA EN PACIENTES CON ICTUS MINOR Y AITS.

IP: Mª Ángeles Muchada López
Collaborators: Carlos Molina Cateriano, Alvaro Garcia Tornel Garcia Camba, Marc Rodrigo Gisbert
Funding agency: Instituto de Salud Carlos III
Funding: 123420
Reference: PI22/01928
Duration: 01/01/2023 - 31/12/2025

Related news

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

Related professionals

Romy Gander

Romy Gander

Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Valentina Balasso

Valentina Balasso

Tècnic/a Superior Recerca
External Strategy Directorate
Read more
Estefania Montiel

Estefania Montiel

Main researcher
Stroke research
Read more
Juan Fernando Fuentes Cabrera

Juan Fernando Fuentes Cabrera

Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.